None listed
Conditions
Interventions
Intervention1: Oryza Acne moisturizer (FD/AHM/2024/S/188): Product is applied on whole face once in a day for period of 28 days.
Control Intervention1: Nil: NA
Sponsors
Alembic Pharmaceuticals Ltd.
Eligibility
Inclusion criteria
Inclusion criteria: 1)Indian female subjects 2)Healthy subjects 3) Skin is healthy on the studied anatomic unit 4) Having mixed oily or oily skin on the face
Exclusion criteria
Exclusion criteria: 1. Being pregnant or breastfeeding or having stopped to breastfeed in the past three months. 2. Having refused to give his/her assent by not signing the consent form and Informed consent form 3. Taking part in another study liable to interfere with this study 4. Being known diabetic case 5. Known asthma case 6. Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis) 7. Being known thyroid case 8. Being epileptic. 9. Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes or corticosteroid by any route (the only medication permitted is paracetamol) 10. Known case of hypersensitivity. 11. Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. 12. Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Non-comedogenic effectTimepoint: Baseline, Day 14, Day 28 | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin pH balanceTimepoint: Baseline, Day 14, Day 28 | — |
Countries
India
Contacts
Public ContactDr Mohit Lalvani
MASCOT-SPINCONTROL India Pvt. Ltd.
Outcome results
None listed